Expert Pitch
Binghamton University, State University of New York

Fears of coronavirus outbreaks have caused the Dow to plunge 1,000 points, but experts say investors shouldn’t be concerned

Newswise — Binghamton University offers live or pre-taped interviews powered by a state-of-the-art ReadyCamtelevision studio system, available at a moment’s notice. Our system can broadcast live HD audio and video to networks, news agencies, and affiliates interviewing Binghamton faculty, students, and staff. Video is transmitted by VideoLink and fees may apply.

BINGHAMTON, N.Y. -- Today the Dow decreased more than 1,000 points with the rise of coronavirus cases outside China, but Dan McKeever, assistant professor in the School of Management at Binghamton University, says investors shouldn’t be concerned. McKeever says people shouldn’t be worried about the recent drop since it is closely tied to people’s emotional reactions, and every scare, whether it be financial or not, has an effect on the economy. He notes that people should focus more on the long term results and ignore the short term changes. 

McKeever says:

“The stock market is supposed to reflect the value of companies, but it also reflects a lot of human emotion. And so in the short run, when there's big scares like the coronavirus, you'll have people reacting emotionally. There's uncertainty about how this is going to affect things like the global supply chain. China's a huge producer. They're also a major consumer. And so if people are sick, they're not going to work and they're not buying things. How bad is this virus going to get? We don't really know. So because we don't know how bad the virus is going to get, investors I think are understandably spooked about the potential long run consequences for the global economy and you're seeing that with this really sharp drop, short, sharp drop in the s&p 500.”

McKeever, an assistant professor in Binghamton University’s School of Management, is an expert on empirical and behavioral corporate finance, board networks, and corporate governance. He received his B.A. in economics and journalism in 2010 from The Ohio State University, and his Ph.D. in finance from Penn State University’s Smeal College of Business in 2018. 




Filters close

Showing results

110 of 2539
Released: 13-Jul-2020 4:05 PM EDT
OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available
Organization for Associate Degree Nursing (OADN)

OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available

Newswise: John Theurer Cancer Center Part of a New Study
in COVID-19 Patients Suggesting Activity of a Novel Agent BTK Inhibitor Acalabrutinib used as Anti-Cancer Drug in B-cell Malignancies
Released: 13-Jul-2020 3:45 PM EDT
John Theurer Cancer Center Part of a New Study in COVID-19 Patients Suggesting Activity of a Novel Agent BTK Inhibitor Acalabrutinib used as Anti-Cancer Drug in B-cell Malignancies
Hackensack Meridian Health

The mechanisms of action of acalabrutinib led to the hypothesis it might be effective in reducing the massive inflammatory response seen severe forms of COVID19. Indeed, it did provide clinical benefit in a small group of patients by reducing their inflammatory parameters and improving their oxygenation.

Newswise: National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Released: 13-Jul-2020 3:40 PM EDT
National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Department of Energy, Office of Science

To focus its efforts against the COVID-19 pandemic, DOE is bringing the national laboratories together into the National Virtual Biotechnology Laboratory.

Newswise: Key Insights from Swedish Casino that Remained Open During COVID-19
Released: 13-Jul-2020 3:40 PM EDT
Key Insights from Swedish Casino that Remained Open During COVID-19
University of Nevada, Las Vegas (UNLV)

As casinos in Las Vegas enter the second month of reopening since the COVID-19 pandemic took hold, UNLV gaming researchers say they can draw upon insights from industry collaborators in Sweden, a country that took a more open approach to the crisis compared to other governments.

Released: 13-Jul-2020 3:05 PM EDT
Asymptomatic Transmission and Reinfection of COVID: Live Event for July 16, 2PM EDT
Newswise

Emerging data shows more risk of asymptomatic transmission and reinfection with COVID than previously thought. Experts will discuss these findings and what are the implications for managing the pandemic. Media are invited to attend and ask questions.

Released: 13-Jul-2020 2:40 PM EDT
Engineered llama antibodies neutralize COVID-19 virus
Rosalind Franklin Institute

Antibodies derived from llamas have been shown to neutralise the SARS-CoV-2 virus in lab tests, UK researchers announced today.

Released: 13-Jul-2020 1:25 PM EDT
1 in 3 young adults may face severe COVID-19
University of California, San Francisco (UCSF)

As the number of young adults infected with the coronavirus surges throughout the nation, a new study by researchers at UCSF Benioff Children's Hospitals indicates that youth may not shield people from serious disease.

Released: 13-Jul-2020 12:25 PM EDT
Scientists discover key element of strong antibody response to COVID-19
Scripps Research Institute

A team led by scientists at Scripps Research has discovered a common molecular feature found in many of the human antibodies that neutralize SARS-CoV-2, the coronavirus that causes COVID-19.

Released: 13-Jul-2020 11:15 AM EDT
UTHealth joins study of blood pressure medication’s effect on improving COVID-19 outcomes
University of Texas Health Science Center at Houston

An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is underway at Memorial Hermann and Harris Health System’s Lyndon B. Johnson Hospital.


Showing results

110 of 2539

close
1.9809